NeumoVigo I+i
Pfizer (United States)
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Pfizer (United States) (1)
2023
-
Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
Microorganisms, Vol. 11, Núm. 11